Rituximab followed by cladribine in the treatment of heavily pretreated patients with indolent lymphoid malignancies. (Q33361984)
scientific article
Language:
Current Data About Rituximab followed by cladribine in the treatment of heavily pretreated patients with indolent lymphoid malignancies.
(P31) (Q13442814)
(P248)
(P698) 15291352
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15291352%20AND%20SRC:MED&resulttype=core&format=json
(P813) Tuesday, December 31, 2019

(P50) (Q58853027)
(P1545) 4
(P248)
(P698) 15291352
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15291352%20AND%20SRC:MED&resulttype=core&format=json
(P813) Tuesday, December 31, 2019

(Q87746991)
(P1545) 1
(P1932) Tadeusz Robak
(P248)
(P698) 15291352
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15291352%20AND%20SRC:MED&resulttype=core&format=json
(P813) Tuesday, December 31, 2019

(Q88929410)
(P1545) 2
(P1932) Piotr Smolewski
(P248)
(P698) 15291352
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15291352%20AND%20SRC:MED&resulttype=core&format=json
(P813) Tuesday, December 31, 2019

(Q114333833)
(P1545) 6
(P1932) Marek Kasznicki
(P248)
(P698) 15291352
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15291352%20AND%20SRC:MED&resulttype=core&format=json
(P813) Tuesday, December 31, 2019

(Q114333794)
(P1545) 5
(P1932) Jerzy Z Blonski
(P248)
(P698) 15291352
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15291352%20AND%20SRC:MED&resulttype=core&format=json
(P813) Tuesday, December 31, 2019

(Q114333812)
(P1545) 3
(P1932) Halina Urbanska-Rys
(P248)
(P698) 15291352
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15291352%20AND%20SRC:MED&resulttype=core&format=json
(P813) Tuesday, December 31, 2019

(P304) 937-944
(P248)
(P698) 15291352
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15291352%20AND%20SRC:MED&resulttype=core&format=json
(P813) Tuesday, December 31, 2019

(P407) (Q1860)

(P433) 5
(P248)
(P698) 15291352
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15291352%20AND%20SRC:MED&resulttype=core&format=json
(P813) Tuesday, December 31, 2019

(P478) 45
(P248)
(P698) 15291352
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15291352%20AND%20SRC:MED&resulttype=core&format=json
(P813) Tuesday, December 31, 2019

(P577) Saturday, May 1, 2004
(P248)
(P698) 15291352
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15291352%20AND%20SRC:MED&resulttype=core&format=json
(P813) Tuesday, December 31, 2019

(P921) (Q412323)
(P887)

(P1433) (Q6534493)
(P248)
(P698) 15291352
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15291352%20AND%20SRC:MED&resulttype=core&format=json
(P813) Tuesday, December 31, 2019

(P1476) "Rituximab followed by cladribine in the treatment of heavily pretreated patients with indolent lymphoid malignancies" (language: en)
(P248)
(P698) 15291352
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15291352%20AND%20SRC:MED&resulttype=core&format=json
(P813) Tuesday, December 31, 2019

(P2860) (Q34926739)
(P248)
(P854) https://api.crossref.org/works/10.1080%2F1042819032000159825
(P813) Sunday, January 21, 2018

(Q33344749)
(P248)
(P854) https://api.crossref.org/works/10.1080%2F1042819032000159825
(P813) Sunday, January 21, 2018

(Q25938997)
(P248)
(P854) https://api.crossref.org/works/10.1080%2F1042819032000159825
(P813) Sunday, January 21, 2018

(Q35018138)
(P248)
(P854) https://api.crossref.org/works/10.1080%2F1042819032000159825
(P813) Sunday, January 21, 2018

(Q35090605)
(P248)
(P854) https://api.crossref.org/works/10.1080%2F1042819032000159825
(P813) Sunday, January 21, 2018

other details
description scientific article

External Links
(P356) 10.1080/1042819032000159825
(P698) 15291352